Literature DB >> 26209941

Case of Concurrent MTC and PTC in a Patient with a Germline RET Mutation.

Kinjal Shah1, Mohsen Zena, Edward D Adickes, Robert J Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26209941     DOI： 10.1007/s12022-015-9381-8

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN： 1046-3976            Impact factor:   3.943


× No keyword cloud information.
  8 in total

Review 1.  Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature.

Authors:  Benedetta Fibbi; Pamela Pinzani; Francesca Salvianti; Matteo Rossi; Luisa Petrone; Maria Laura De Feo; Roberto Panconesi; Vania Vezzosi; Simonetta Bianchi; Gabriele Simontacchi; Monica Mangoni; Maurizio Pertici; Gianni Forti; Cinzia Pupilli
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

2.  Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.

Authors:  Diana L Learoyd; Jessica Gosnell; Marianne S Elston; Tricia J Saurine; Anne-Louise Richardson; Leigh W Delbridge; John V Aglen; Bruce G Robinson
Journal:  Clin Endocrinol (Oxf)       Date:  2005-12       Impact factor: 3.478

3.  Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation.

Authors:  G L Feldman; M W Edmonds; P J Ainsworth; I Schuffenecker; G M Lenoir; A W Saxe; G B Talpos; J Roberson; N Petrucelli; C E Jackson
Journal:  Surgery       Date:  2000-07       Impact factor: 3.982

4.  Synchronous metastatic medullary and papillary thyroid carcinomas in a patient with germline RET mutation: case report, molecular analysis, and implications for pathogenesis.

Authors:  Christopher Griffith; Shengle Zhang; Sanjay Mukhopadhyay
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

5.  One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?

Authors:  Alexander L Shifrin; Cristina Xenachis; Angela Fay; Theodore J Matulewicz; Yen-Hong Kuo; Jerome J Vernick
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

6.  Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene.

Authors:  L Foppiani; F Forzano; I Ceccherini; W Bruno; P Ghiorzo; F Caroli; P Quilici; R Bandelloni; A Arlandini; G Sartini; M Cabria; P Del Monte
Journal:  Eur J Endocrinol       Date:  2008-03       Impact factor: 6.664

7.  Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation.

Authors:  G Papi; S Corrado; M G Pomponi; C Carapezzi; A Cesinaro; V A LiVolsi
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

8.  Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation.

Authors:  Michael Brauckhoff; Oliver Gimm; Raoul Hinze; Jörg Ukkat; Katrin Brauckhoff; Henning Dralle
Journal:  Thyroid       Date:  2002-07       Impact factor: 6.568
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.